Premium
Value of Biomarkers in the Prevention of Rheumatoid Arthritis
Author(s) -
Finckh A,
AlpizarRodriguez D,
RouxLombard P
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.727
Subject(s) - rheumatoid arthritis , medicine , intensive care medicine , family history , clinical history , biomarker , biochemistry , chemistry
Recent diagnostic advances allow to identify persons in a pre‐symptomatic stage of rheumatoid arthritis (RA), opening the way for a preventive therapeutic intervention, which may potentially be curative. We review and discuss existing biomarkers predictive of future onset of RA. A responsible use of biomarkers in clinical settings will require an integration of blood‐based tests, imaging techniques, clinical history, environmental risk factors, and family history.